Who
Daniel M. Schmitt
President, CEO and Director
Company insider
Files Form 4 as: President, CEO and Director, Actuate Therapeutics; VP, Licensing & Comm Dev., Immtech International.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 24 Jan 2006
- Last trade
- 14 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 14 Aug 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code M | —272,056 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code F | $122K120,521 at $1.01 | filing |
| 14 Aug 2026filed 14 Aug 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —272,056 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —272,056 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code M | —272,056 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code F | $122K120,521 at $1.01 | filing |
| 1 Apr 2026filed 1 Apr 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —237,000 at $0.00 | filing |
| 1 Apr 2026filed 1 Apr 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —237,000 at $0.00 | filing |
| 13 Feb 2026filed 13 Feb 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code M | —272,055 at $0.00 | filing |
| 13 Feb 2026filed 13 Feb 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code F | $528K121,874 at $4.33 | filing |
| 13 Feb 2026filed 13 Feb 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —272,055 at $0.00 | filing |
| 13 Feb 2026filed 13 Feb 2026 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —272,055 at $0.00 | filing |
| 13 Feb 2026filed 13 Feb 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code M | —272,055 at $0.00 | filing |
| 13 Feb 2026filed 13 Feb 2026 | ACTU Actuate TherapeuticsBiotechnology | SEC FORM 4 Code F | $528K121,874 at $4.33 | filing |
| 1 Apr 2025filed 2 Apr 2025 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,503 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —204,285 at $0.00 | filing |
| 14 Aug 2024filed 14 Aug 2024 | ACTU Actuate Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —544,111 at $0.00 | filing |
| 24 Jan 2006filed 26 Jan 2006 | Immtech Internationaloption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.